CONFERENCE COVERAGE
Conference on Retroviruses and Opportunistic Infections
Annual Meeting
2020 COVERAGE
- PrEP Care Continuum Among Certain Patient Populations in the United States
- Raltegravir-Based ART Shows Lower Rates of Hepatoxicity
- CMV-Specific Immune Response in Advanced HIV Infections
- Two-Drug Regimens Comparable With Three-Drug Regimens for HIV
- The Renal-Bone Axis and ART in Adolescents and Elderly With HIV
- Discontinuation of Dolutegravir Due to Neurologic Side Effects Linked to Pre-Existing Mental Illness
- Long-Acting Cabotegravir + Rilpivirine Noninferior to Standard Treatment for HIV
- Dried Blood Spot Viral Load More Accurate Than Plasma Viral Load in HIV?
- Buprenorphine Treatment Linked to Decreased HIV RNA Viral Loads
- Cardiac Events Significantly Higher With TAF vs TDF Treatment for HIV
- Pulmonary Tuberculosis Enhances HIV-1 Antibody Responses
- Sofosbuvir/Velpatasvir Combination Therapy Efficacious in HCV/HIV Coinfection
Latest Tweets
Follow
@InfectDiseaseAd
Conference Coverage from
